Genetic Basis of Orthopedic Diseases



Fig. 14.1
X-ray of a 68-year-old female patient. Right hip fracture due to severe osteoporosis



A 65-year-old female patient, who has a 68-year-old sister operated because of a femoral neck fracture due to osteoporosis, approached the outpatient clinic for bone mass density tests and asking if she is genetically prone to fracture due to osteoporosis because of her sister.

What we have in our hands about the genetic basis of osteoporosis is very limited, involving many functional variants [20]. This is similar for other complex human diseases representing serious health problems like diabetes and obesity. Recent advances in next-generation sequencing technologies have greatly enhanced our ability to discover functional rare variants. But on the other hand; these technologies are very expensive to be applied for whole population [21].

It is estimated that osteoporosis affects more than 75 % of women 70 years of age. Fractures related to osteoporosis result in significant morbidity and increased mortality. It is generally classified as primary or secondary (due to endocrine dysfunction, medications, and inflammatory disorders).

According to bone mass density, genetic variations are estimated to be more than 70 % to cause such differences [22]. And according to the femoral neck geometry and bone turnover, these variations are between 50 and 80 % [23]. Besides, the heritability of fracture itself is relatively low, close to 25 % due to fall-related factors such as vision, balance, and strength [24].


Genetic disorders involving the skeletal system with their great variety in number occur due to any kind of mutation in skeletal development.

The recent years have witnessed major advances in our understanding of the genetic basis for many skeletal disorders. By means of technological improvement, the responsible gene for each disorder has been mapped, and the exact locus has been defined, the mutations clearly shown, and the functional significance of mutations determined; these are all important steps to clarify the molecular basis for pathogenesis.

In this chapter, we focus on our current understanding of the genetic basis and pathogenic mechanisms for disorders of bone homeostasis.

For researchers who are interested in genetics, Online Mendelian Inheritance in Man (http://​www.​ncbi.​nlm.​nih.​gov/​omim) and the human genome database are important and serve as a database.

From these databases, we have a long list of genes involved in skeletal disorders (Table 14.1).


Table 14.1
Name of the genes and their function with the skeletal disorders involved



































































































































































































Gene

Disease

Gene function

ARSE

Chondrodysplasia punctate

Unknown

ANKH

Premature osteoarthrosis with chondrocalcinosis

Transport molecule

Cathepsin K

Pyncodysostosis
 

CBFA1

Cleidocranial dysplasia

Transcription molecule

C7orf2

Preaxial polydactyly

Signaling molecule

COL1A1, COL1A2

Osteogenesis imperfecta I–IV

Structural molecule

COL2A1

Achondrogenesis II

Structural molecule

Hypochondrogenesis

Kniest dysplasia

Spondyloepiphyseal dysplasia congenital

Stickler’s syndrome 1

COL9A2

Multiple epiphyseal dysplasias

Structural molecule

COL10A1

Schmid metaphyseal chondrodysplasia

Structural molecule

COMP

Multiple epiphyseal dysplasias

Structural molecule

Pseudoachondroplasia

DTDST

Diastrophic dysplasia

Transport molecule

Ehlers-Danlos syndrome (autosomal recessive)

Achondrogenesis 1 B

Atelosteogenesis II

EBP

Chondrodysplasia punctate, x-linked type 2

Signaling pathway molecule

EVC

Ellis-van Creveld syndrome

Unknown

FBLN1

Complex synpolydactyly (one form)

Structural molecule

FGFR3

Achondroplasia

Cell-signaling molecule

Hypochondroplasia

Thanatophoric dysplasias I–II

FGFR2

Apert syndrome

Cell-signaling molecule

Crouzon syndrome

Pfeiffer syndrome (most)

FGFR1

Pfeiffer syndrome (some)

Cell-signaling molecule

GLI3

Greig cephalopolysyndactyly

Transcription factor

Pallister-Hall syndrome

Postaxial polydactyly type A/B

HOXA13

Hand-foot-genital syndrome

Transcription factor

HOXD13

Synpolydactyly

Transcription factor

Brachydactyly D/E and A1

LMX1B

Nail-patella syndrome

Transcription factor

MATN3

Ehlers-Danlos syndrome (autosomal dominant)

Structural molecule

Hand osteoarthrosis

MSX2

Boston-type craniosynostosis

Transcription factor

OFD1

Oral-facial-digital type I syndrome

Unknown

P63

Split hand/split foot

Cell-signaling protein

Ectrodactyly-ectodermal dysplasia

ADULT syndrome

PEX7

Chondrodysplasia punctate type I

Transcription factor

PTH

Jansen’s metaphyseal chondrodysplasia

Cell-signaling factor

ROR2

Brachydactyly type B

Cell-signaling factor

Robinow syndrome

SALL1

Townes-Brocks syndrome

Transcription factor

SEDL

X-linked spondyloepiphyseal dysplasia

Transport molecule

SHOX

Leri-Weill dyschondrosteosis

Transcription factor

Idiopathic short stature (some)

Langer mesomelic dysplasia

Turner syndrome (part of)

SOST

Bone dysplasia sclerosteosis

Unknown

SOX9

Campomelic dysplasia

Transcription factor

TBX3

Ulnar-mammary syndrome

Transcription factor

TBX5

Holt-Oram syndrome
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 3, 2016 | Posted by in MUSCULOSKELETAL MEDICINE | Comments Off on Genetic Basis of Orthopedic Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access